Safety Study of a Capsule-Conjugate Vaccine to Prevent Campylobacter-Caused Diarrhea
Status:
Completed
Trial end date:
2016-01-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety of increasing doses of a potential vaccine
against Campylobacter with and without Alhydrogel®, an aluminum hydroxide adjuvant. This
study will also assess immune responses induced by the vaccine.
Phase:
Phase 1
Details
Lead Sponsor:
U.S. Army Medical Research and Development Command U.S. Army Medical Research and Materiel Command